KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Other Non Operating Income (2016 - 2025)

Opko Health's Other Non Operating Income history spans 16 years, with the latest figure at -$960000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to -$960000.0; the TTM value through Dec 2025 reached -$29.9 million, changed N/A, while the annual FY2025 figure was -$29.9 million, 114.44% down from the prior year.
  • Other Non Operating Income reached -$960000.0 in Q4 2025 per OPK's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $58.9 million in Q2 2024 to a low of -$73.0 million in Q2 2022.
  • Average Other Non Operating Income over 5 years is -$4.7 million, with a median of -$960000.0 recorded in 2025.
  • Peak YoY movement for Other Non Operating Income: tumbled 3547.69% in 2022, then skyrocketed 1280.1% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $1.3 million in 2021, then crashed by 3547.69% to -$44.8 million in 2022, then skyrocketed by 97.88% to -$949000.0 in 2023, then skyrocketed by 5224.97% to $48.6 million in 2024, then crashed by 101.97% to -$960000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPK's Other Non Operating Income are -$960000.0 (Q4 2025), $1.7 million (Q3 2025), and -$35.5 million (Q2 2025).